William A. Sheremata, MD
Affiliations: | Neurology | University of Miami, Coral Gables, FL |
Google:
"William Sheremata"Bio:
Univ Miami School of Medicine
Dept Neurology
1501 NW 9th Ave, D4-5
Miami, FL 33101
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sheremata W, Brown AD, Rammohan KW. (2015) Dimethyl fumarate for treating relapsing multiple sclerosis. Expert Opinion On Drug Safety. 14: 161-70 |
| Perzova R, Graziano E, Sanghi S, et al. (2015) Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy. Aids Research and Human Retroviruses. 31: 242-9 |
| Tornes L, Conway B, Sheremata W. (2014) Multiple sclerosis and the cerebellum. Neurologic Clinics. 32: 957-77 |
| Delgado SR, Lavi ES, Campos YA, et al. (2014) Natalizumab Associated PML in a Multiple Sclerosis Patient: Excellent Response to Minimal Intervention Journal of Multiple Sclerosis. 1: 1-4 |
| Sheremata W, Tornes L. (2013) Multiple Sclerosis and the Spinal Cord Neurologic Clinics. 31: 55-77 |
| Sheremata WA, Sazant A, Riesgo V, et al. (2013) Intrathecal IgG synthesis in relapsing-remitting multiple sclerosis (MS) is decreased by natural human alpha interferon Advances in Bioscience and Biotechnology. 4: 1-5 |
| Usmani N, Bedi G, Lam BL, et al. (2012) Association between paroxysmal tonic spasms and neuromyelitis optica. Archives of Neurology. 69: 121-4 |
| Bedi GS, Brown AD, Delgado SR, et al. (2011) Impact of rituximab on relapse rate and disability in neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1225-30 |
| Delgado SR, Sheremata WA, Brown AD, et al. (2010) Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports. Journal of Neurovirology. 16: 249-53 |
| Delgado S, Baez S, Singer C, et al. (2009) Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 309-11 |